PRE 14A

PRELIMINARY PROXY STATEMENT

Company: ADIAL PHARMACEUTICALS, INC.
Filed: November 24, 2023
Period of Report: November 24, 2023
Accession Number: 0001213900-23-089748

View Document ↗ View on SEC.gov ↗